Modulight: Checking estimates ahead of the Q2 report
Our Q2 estimates have expected strong growth from the company, based on the start of commercialization of the ophthalmic laser during Q2'23. The company has also referred to other projects with significant revenue potential in 2023. We are lowering our Q2 estimates as there was no news on these growth drivers during Q2. We will look at our estimates for the rest of the year and the coming years as well as our recommendation in next week's report.
Modulight
Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.
Read more on company pageKey Estimate Figures2023-08-11
2022 | 23e | 24e | |
---|---|---|---|
Revenue | 4.6 | 8.7 | 12.6 |
growth-% | -49.30 % | 89.02 % | 44.86 % |
EBIT (adj.) | -7.8 | -5.7 | -2.9 |
EBIT-% (adj.) | -169.49 % | -65.96 % | -22.70 % |
EPS (adj.) | -0.20 | -0.13 | -0.06 |
Dividend | 0.00 | 0.00 | 0.00 |
Dividend % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | - | - | - |